DuPuy Hip Replacement Cases
We’ve written in the past about hip replacement implant recalls and lawsuits against Johnson & Johnson. Recently one of Johnson & Johnson’s subsidiary companies, DuPuy Orthopedics has been involved in a number of cases surrounding defective hip replacement implants.
These medical devices have been recalled due to the fact that they caused a number of complications in patients that received them. Patients reported symptoms such as pain, difficulty standing, limited mobility, loosening of the prosthetic joint, metal poisoning and hip replacement failure. Many of these patients required a second surgery to correct the first one.
It’s not uncommon for there to be complications when it comes to risky surgeries; however, the reason DuPuy is being held responsible is partly due to the fact that they did not conduct sufficient premarket testing. As a result they are currently embroiled in a series of bellweather trials to settle the claims.
The point of a bellweather trial is to address multiple claims over the same issue. The patients who experienced negative side effects from their DuPuy hip replacement implants were able to have their case heard through this bellweather trial. That way one judge could make a decision on a large number of cases, rather than having multiple judges view each case individually. This not only helps with the speed at which these cases are settled, but also with the consistency of the outcomes of these cases.
The third DuPuy Hip Replacement Implant Trial concluded at the end of 2016. As a result, Johnson & Johnson was forced to pay $1 billion in punitive damages on top of $32 million in compensation.
If you or someone you know has been injured by a defective hip implant, don’t hesitate to contact an attorney. Make sure you have someone on your side who can help you stand up to big pharmaceutical companies.
Is Permanent Hair Loss Caused By Taxotere Grounds for a Case?
For many cancer patients, hair loss is a common side effect that comes with chemotherapy. Commonly referred to as “alopecia” in the medical field, hair loss from chemotherapy is supposed to be temporary. However, recently a group of breast cancer survivors found that they were unable to regrow their hair. They were surprised by this, as they were never warned that permanent hair loss was a possible outcome.
It turns out that their permanent alopecia was caused by a chemotherapy drug called “Taxotere.” Taxotere has been approved by the USDA; however, this side effect was not on record. Had the cancer patients known that this drug caused permanent hair loss, they could have chosen an alternative treatment option. One such option would have been Taxol.
It would have been one thing if the manufacturer, Sanofi-Aventis, truly didn’t know that this was a possible side effect; however, evidence shows that they should have known about it as early as 2005. As many as 10-15% of patients who took Taxotere experienced permanent hair loss.
Currently, cases are being filed against Sanofi-Aventis all across the country for permanent hair loss caused by Taxotere. It’s likely that soon these cases will become a part of a multidistrict litigation, which means all of the cases will be handled by one judge.
If you or a loved one has experienced permanent hair loss as a result of Taxotere, don’t hesitate to contact us for a free consultation. Cases such as these are often time sensitive, so you’ll want to make sure you file your claim before the statute of limitations runs out.
If you’ve experienced side effects from a drug that you were not warned about, then there’s a good chance you have a case. Don’t hesitate to contact our experienced attorneys for a free consultation.
A Bad Year for Johnson & Johnson
If you’ve been keeping up with our blog, then you probably know that Johnson & Johnson faced some substantial cases last year. In fact, the company has been engaged in six of the seven biggest product defect cases of 2016. And the verdicts did not play out in their favor. They are likely to end up losing millions of dollars as a result.
Johnson & Johnson started 2016 off with their first major case involving a defective blood-thinner, Xeralto, which caused uncontrollable bleeding in some patients. They also were involved in two major defective hip implant cases and two cases involving talcum powder and ovarian cancer. The sixth case was over their drug Risperdal, which caused the boys who took it to develop female breasts. In all 6 of these cases, Johnson & Johnson was forced to settle for anywhere from $55 million to $1 billion.
The important thing about cases such as these is that they can end up becoming more and more expensive for a company, even after the cases have settled. Many people worry that they won’t be able to stand up in court to a big company such as Johnson & Johnson. However, once they see that someone with a similar case has been successful, more and more victims start stepping forward.
Everyone who’s been wrongfully harmed by a prescription drug or medical device that was supposed to help them deserves to have their case heard and to be rightfully compensated. If you’ve been injured as a result of a faulty product, don’t hesitate to reach out to an experienced attorney like the caring and determined team members we have at Oxner + Permar. We can help you stand up to the big corporations and get the benefits you deserve.
With more than $257 million in awards and settlements, the attorneys at Oxner + Permar have the experience to stand up to big corporations and ensure that your rights are protected.
Stryker Orthopedic Medical Device Recall
In 2012, Stryker Orthopedics was forced to issue a hip device recall of one of their widely used modular hip stem devices. After a number of lawsuits, Stryker finally agreed to a settlement of $1.4 billion for the product liability and personal injury claims against them — and it looks like Stryker Orthopedics is going to be in a similar situation again this year. There have been multiple reports that one of their devices has either been breaking at the stem or causing metal poisoning. Both instances cause the patient to need emergency revision surgery.
Of course, this is a huge problem. As the metal joints rub against each other, they begin to corrode. This weakens the head-neck juncture of the implant causing it to eventually break. It also can cause severe pain for the patient as well as higher metal levels. This is what leads to metal poisoning or “metallosis.”
Unfortunately this is not a problem that can simply be repaired; the patient will need a new device entirely. This poses additional risk for patients whose bodies are already adapting to one hip surgery. They are being exposed to the risk of infection or other complications expected from a hospital setting. Moreover, these devices are attached directly to the patient’s bone. They’re not designed to be replaced, and oftentimes, a surgeon will have to break the femur in order to remove the device, causing additional strain on the patient’s body.
Even once this corrective surgery is finished, there is no guarantee that the patient will be alleviated of their problems. In fact, in all likelihood, long-term problems will persist. As such, those affected by this defect should be entitled to compensation.
If you or someone you know has been affected by a defective orthopedic device, be sure to contact an experienced attorney. You deserve compensation for your pain and trauma.
Woman Awarded $70 Million in a Case Against Johnson & Johnson
It’s always scary to hear about companies failing to warn consumers about the dangers of their products. Ideally, you hope that companies will have the best interests of their consumers in mind. However — when something does slip through the cracks, and a product that’s unsafe or has potential dangerous side effects goes to market, it’s always good to hear about the court system standing by the consumers.
A court recently found Johnson & Johnson guilty of not informing their consumers of the connection between the use of their talcum powder and ovarian cancer. Deborah Giannecchini had been using Johnson & Johnson talcum powder as a feminine hygiene product for more than 40 years. Three years ago she was diagnosed with ovarian cancer.
According to Giannecchini’s lawyer, Johnson & Johnson had been presented with 30 years worth of studies linking talcum powder to ovarian cancer. It was clear to the jury, who ruled in favor of the plaintiff, that Johnson & Johnson should have been warning their customers about this risk. Giannecchini was awarded more than $70 million.
Giannecchini was not alone in her claim. Around 1,700 others have filed similar claims against Johnson & Johnson. If you or a loved one have been diagnosed with ovarian cancer as a result of talcum powder use, be sure to contact an attorney to find out if you are eligible for compensation.
When big businesses fail to protect us, it’s always good to turn to an experienced lawyer, someone who has your back and will fight for you. At Oxner + Permar, we’re passionate about protecting our client’s rights.